Publications
14
Citations
18
Est. group size
—
Recurring co-author estimate
Active years
7
Publishing since 2020
Sanya J. Thomas's research focuses on infections and vaccines in vulnerable pediatric and immunocompromised populations, including organ and stem cell transplant recipients. Work spans viral infections (such as cytomegalovirus, adenovirus, hepatitis B, and RSV), vaccine immunogenicity, and clinical outcomes related to transplantation. This research is largely clinical and translational, drawing on case studies, cohort data, and vaccine trials.
Publication activity has been irregular but has increased in recent years, with a notable uptick in output from 2023 through 2026 after a period of low activity earlier in the decade.
Generated by claude-sonnet-5 from public bibliographic data · Jul 20, 2026
- P-1422. Immunogenicity and Reactogenicity of Adjuvanted (Arexvy) and Non-Adjuvanted (Abrysvo) RSV Vaccines in Immunocompromised Individuals with Hematological Malignancies
Open Forum Infectious Diseases · 2026
- A randomized prospective study of neonatal hepatitis B vaccine immunogenicity in The Gambia and Papua New Guinea
Journal of Allergy and Clinical Immunology Global · 2026
- Case Report: Pseudomonas liver abscess in a previously healthy child with homozygous pathogenic S allele variant of the SERPINA1 gene
Frontiers in Immunology · 2026
- Updates on Vaccine‐Preventable Respiratory Viral Infections in Pediatric Solid Organ Transplant Recipients
Pediatric Transplantation · 2025
- (275) Early Renal Outcomes Following Cardiac Transplantation Using Organs Procured after Circulatory Death
The Journal of Heart and Lung Transplantation · 2023
- 412. Estimating the Impact of School Classroom Sizes on the Probability of Severe Acute Respiratory Syndrome Coronavirus-2 Infectivity or Exposure
Open Forum Infectious Diseases · 2021
- Risks and outcomes of adenovirus disease in pediatric hematopoietic stem cell transplant recipients—Comparison of current antiviral treatment options
Transplant Infectious Disease · 2020
- Raltegravir-associated Drug-Reaction With Eosinophilia and Systemic Symptoms Syndrome in a Pediatric Patient Without Characteristic Human Leukocyte Antigen B*57:01 or B*53:01 alleles
Journal of the Pediatric Infectious Diseases Society · 2020
- 1411. Risks and Outcomes of Adenovirus Disease in Pediatric HSCT Recipients –Comparison of Current Antiviral Treatment Options
Open Forum Infectious Diseases · 2020
- Open Forum Infectious Diseases×3
- Transplant Infectious Disease×2
- Journal of the Pediatric Infectious Diseases Society×2
- Pediatric Transplantation×1
- American Journal of Transplantation×1
- Tuan L. Phan
Medicine · The Ohio State University
- Christopher P. Ouellette
Medicine · The Ohio State University
- Alexandra K Medoro
Medicine · The Ohio State University
- Eunkyung Song
Medicine · The Ohio State University
- Masako Shimamura
Medicine · The Ohio State University
This profile was generated automatically from public scholarly data (OpenAlex). Group size and activity levels are estimates derived from co-authorship patterns.
Last updated Jul 19, 2026.
Claim or correct this profile